Literature DB >> 5004178

Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride and glisoxepide. I. Dose response relations and repeated administration in diabetic subjects.

E Haupt, W Köberich, J Beyer, K Schöffling.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5004178     DOI： 10.1007/bf01212061

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  9 in total

1.  A simplified method for immuno-assay of human serum insulin.

Authors:  R C MEADE; H M KLITGAARD
Journal:  J Nucl Med       Date:  1962-09       Impact factor: 10.057

2.  [Mechanism of action of hypoglycemic sulfonyl urea compounds, D 860 & BZ 55].

Authors:  A BANDER
Journal:  Dtsch Med Wochenschr       Date:  1959-05-22       Impact factor: 0.628

3.  Microdetermination of long-chain fatty acids in plasma and tissues.

Authors:  V P DOLE; H MEINERTZ
Journal:  J Biol Chem       Date:  1960-09       Impact factor: 5.157

Review 4.  [Current pathophysiological and clinical aspects of the mode of action of blood glucose lowering sulfonamides].

Authors:  E F Pfeiffer
Journal:  Acta Diabetol Lat       Date:  1969-09

5.  [Clinical experiences with oral antidiabetic HB 419 (glibenclamide)].

Authors:  K Schöffling; R Petzoldt; C Althoff-Zucker; J Beyer; K Retiene; E Böhle; W Kunkel
Journal:  Arzneimittelforschung       Date:  1969-08

6.  [Further studies on the dynamic aspects of insulin release in vitro with evidence for a two-compartmental storage system].

Authors:  G M Grodsky; D Curry; H Landahl; L Bennett
Journal:  Acta Diabetol Lat       Date:  1969-09

7.  [Glybenclamide (HB 419): a new oral antidiabetic agent of the sulfonylurea group].

Authors:  H Mehnert; E Karg
Journal:  Dtsch Med Wochenschr       Date:  1969-04-18       Impact factor: 0.628

8.  [On radio-immunologic determination of insulin in blood].

Authors:  F Melani; H Ditschuneit; K M Bartelt; H Friedrich; E F Pfeiffer
Journal:  Klin Wochenschr       Date:  1965-09-15

9.  [Experimental study of a new especially active hypoglycemic sulfonamide, HB-419 or Glibenclamide].

Authors:  A Loubatières; M M Mariani; G Ribes; H de Malbosc; J Chapal
Journal:  Diabetologia       Date:  1969-02       Impact factor: 10.122
  9 in total
  11 in total

1.  [Clinical pharmacology of two new oral antidiabetics of the sulfonamide type (author's transl)].

Authors:  E Haupt; K A Küllmer; K Schöffling
Journal:  Klin Wochenschr       Date:  1977-07-15

2.  [Recent findings in the use of 1st and 2nd generation hypoglycemic sulfonamides].

Authors:  K Schöffling; E Haupt; W Köberich; J Beyer
Journal:  Klin Wochenschr       Date:  1973-01-15

Review 3.  The relationship between the pharmacokinetics and pharmacodynamic effects of oral hypoglycaemic drugs.

Authors:  R E Ferner; S Chaplin
Journal:  Clin Pharmacokinet       Date:  1987-06       Impact factor: 6.447

4.  Long-term effects of glibenclamide on the insulin production, oxidative metabolism and quantitative ultrastructure of mouse pancreatic islets maintained in tissue culture at different glucose concentrations.

Authors:  L A Håkan Borg; A Andersson
Journal:  Acta Diabetol Lat       Date:  1981

Review 5.  Clinical pharmacokinetics of sulphonylurea hypoglycaemic drugs.

Authors:  L Balant
Journal:  Clin Pharmacokinet       Date:  1981 May-Jun       Impact factor: 6.447

6.  Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride, and glisoxepide. II. Repeated administration in combination with glucose.

Authors:  E Haupt; W Köberich; J Beyer; K Schöffling
Journal:  Diabetologia       Date:  1971-12       Impact factor: 10.122

7.  Insulin release by tolbutamide and glibenclamide. A comparative study on the perfused rat pancreas.

Authors:  H G Joost; A Hasselblatt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-04       Impact factor: 3.000

8.  Binding of hypoglycaemic sulphonylureas to an artificial phospholipid bilayer.

Authors:  M Deleers; W J Malaisse
Journal:  Diabetologia       Date:  1984-01       Impact factor: 10.122

9.  Sulfonylurea-induced factitious hypoglycemia in a nondiabetic nurse.

Authors:  P G Walfish; R P Kashyap; S Greenstein
Journal:  Can Med Assoc J       Date:  1975-01-11       Impact factor: 8.262

10.  An inhibitory effect of tolbutamide and glibenclamide (glyburide) on the pancreatic islets of normal animals.

Authors:  J C Dunbar; P P Foà
Journal:  Diabetologia       Date:  1974-02       Impact factor: 10.122
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.